Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Grass pollen allergen-specific CD4+ T lymphocytes are a specialized subset of memory T cells that drive the allergic immune response to grass pollen antigens, most notably from Timothy grass (Phleum pratense) (Wambre et al., Sci Transl Med, 2011). In allergic individuals, these cells typically exhibit a T helper 2 (Th2) phenotype, characterized by the secretion of cytokines such as IL-4, IL-5, and IL-13, which promote IgE production and eosinophilic inflammation (Durham & Penagos, J Allergy Clin Immunol, 2016). These cells are the primary therapeutic target of allergen immunotherapy (AIT), which seeks to re-establish immunological tolerance to the allergen. AIT induces changes in these T cells, including the induction of anergy, clonal deletion, or a shift toward a regulatory T cell (Treg) or Th1 phenotype (Akdis & Akdis, Nature Reviews Drug Discovery, 2009). By modulating the activity and frequency of these allergen-specific cells, AIT provides long-term relief from symptoms of allergic rhinitis and asthma and can prevent disease progression.
Induction of peripheral T-cell tolerance through the expansion of allergen-specific regulatory T cells (Tregs), induction of T-cell anergy or deletion, and immune deviation from a Th2-polarized response to a Th1-mediated response.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Grass pollen allergen-specific CD4+ T lymphocyte (Grass pollen-specific CD4+ T cell).